COLUMBIA, Md.--(BUSINESS WIRE)--Celsion Corporation (NASDAQ:CLSN), a leading oncology drug development company, today announced that three abstracts on the Company’s proprietary thermosensitive liposome technology and ThermoDox® will be presented at the Society for Thermal Medicine Annual Meeting, April 3-7, at the Marriott University Park Hotel in Tucson, Arizona. The abstracts were submitted by the Company’s collaborative research partners, Duke University and The National Institutes of Health (NIH).
